US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Kuniko Limited (KNIOA) 銘柄情報

Kuniko Limited (KNIOA)

0.006

0.00

( 0.00% )

更新日時： 09:00:00

Kuniko Limited (KNIOA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.006

( - )

買値

0.006

売値

0.006

出来高

0.00

0.00 日の範囲 0.00

0.004 52 週間の範囲 0.008

時価総額

前日終値

0.006

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 1,605,474

発行済株式数

204,613,823

配当利回り

PER

-1

1 株当たり利益 (EPS)

-0.03

歳入

-

純利益

-3.22M

Kuniko Limited engages in mineral exploration activities in Australia and Norway. The company explores for nickel, copper, zinc, and cobalt deposits. Its flagship asset is the Ertelien Project located in southern Norway in Ringerike Municipality. The company was formerly known as Koppar Resources Eu... Kuniko Limited engages in mineral exploration activities in Australia and Norway. The company explores for nickel, copper, zinc, and cobalt deposits. Its flagship asset is the Ertelien Project located in southern Norway in Ringerike Municipality. The company was formerly known as Koppar Resources Europe Pty Ltd. Kuniko Limited was incorporated in 2017 and is headquartered in Perth, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

kuniko.eu

本社

Perth, Australia

設立

2026

Kuniko Limited is listed in the sector of the オーストラリア証券取引所 with ticker KNIOA. The last closing price for Kuniko was AUD0.01. Over the last year, Kuniko shares have traded in a share price range of AUD 0.004 to AUD 0.008.

Kuniko currently has 204,613,823 shares in issue. The market capitalisation of Kuniko is AUD1.23 million. Kuniko has a price to earnings ratio (PE ratio) of -1.00.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.006	0.006	0.006	200000	0.006	DE
4	-0.001	-14.2857142857	0.007	0.007	0.004	1020474	0.00610433	DE
12	0.001	20	0.005	0.008	0.004	1108955	0.00634628	DE
26	0.001	20	0.005	0.008	0.004	1108955	0.00634628	DE
52	0.001	20	0.005	0.008	0.004	1108955	0.00634628	DE
156	0.001	20	0.005	0.008	0.004	1108955	0.00634628	DE
260	0.001	20	0.005	0.008	0.004	1108955	0.00634628	DE

KNIOA - Frequently Asked Questions (FAQ)

What is the current Kuniko Limited share price?

The current share price of Kuniko Limited is AUD 0.006

How many Kuniko Limited shares are in issue?

Kuniko Limited has 204,613,823 shares in issue

What is the market cap of Kuniko Limited?

The market capitalisation of Kuniko Limited is AUD 1.23M

What is the 1 year trading range for Kuniko Limited share price?

Kuniko Limited has traded in the range of AUD 0.004 to AUD 0.008 during the past year

What is the PE ratio of Kuniko Limited?

The price to earnings ratio of Kuniko Limited is -1

What is the registered address of Kuniko Limited?

The registered address for Kuniko Limited is AMP Tower, Perth, Western Australia, 6000

What is the Kuniko Limited website address?

The website address for Kuniko Limited is kuniko.eu

Sleepy$$$

Sleepy$$$ 16分前

Outstanding Shares642,268,09705/29/2026Restricted625,012,64605/29/2026

Per otcmarkets.... float is tiny

Duke Knockem

Duke Knockem 19分前

I asked Belisarian holdings if they would take over Gs tickers, they didn't respond, but they 'liked' my post on Twitter. In 4 years it was only the second time they liked one of my post....🤷....to take with a grain of salt

nowwhat2

nowwhat2 23分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

nowwhat2

nowwhat2 24分前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

axelvento

axelvento 24分前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 32分前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 33分前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 36分前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 37分前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 42分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 43分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 45分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 48分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 49分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 49分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 50分前

Even more reason to transfer full Adderall rights to Elite now. Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 52分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 52分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 55分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 56分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Macallum New Energy

Clara Resources Australia

European Resources

Elixinol Wellness

Optiscan Imaging

European Resources

OncoSil Medical

Ryzon Materials

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。